Hugo R Lara-Martinez: Recognizing HLH After Immune Checkpoint Inhibitor Therapy
Hugo R Lara-Martinez, Former Assistant Professor of Medicine- Hematology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Immunotherapy, adding:
”Excited to share our recently published case series on immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis (HLH).
We highlight the varied clinical presentations, diagnostic challenges, and treatment approaches in this rare but potentially life-threatening hematologic immune-related adverse event.
Grateful to my co-authors for their collaboration.”
Title: Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients
Authors: Mayte G. Martinez-Garza, Effrosyni Apostolidou, Hugo R. Lara-Martinez, Thein H. Oo, Cristhiam M. Rojas-Hernandez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 18:13Ramsha Batool: Chemotherapy-Induced Anemia Impacts Quality of Life in Breast Cancer
-
Sep 1, 2026, 18:09Natalya Shynhera: Using Anemia to Teach Medical English in Real Clinical Practice
-
Sep 1, 2026, 18:06Wei Du: New Therapeutic Potential for PARP Inhibitors in MLL-Rearranged Leukemia
-
Sep 1, 2026, 18:03Tobias Tichelbäcker: PRAGUE-26 Shows Catheter Lysis Beats Anticoagulation Without Ultrasound
-
Sep 1, 2026, 18:00Baptiste Thibault: My First Publication as First Author on Ionized Calcium Monitoring Before Citrate-CRRT
-
Sep 1, 2026, 17:51Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
-
Sep 1, 2026, 17:49Malik Ghannam: Recent Venous Thrombosis Risk Factors May Help Explain Cryptogenic Stroke in Young Adults
-
Sep 1, 2026, 17:42Rishabh Jain: Renal Artery FMD Is Managed With Balloon Angioplasty Alone
-
Sep 1, 2026, 17:42Caitlin R: The Brain’s Need to Find Patterns